drugset / Trial / NCT02501941

Spreading Depolarization and Ketamine Suppression

NCT02501941

Phase 1 Completed 10 enrolled University of New Mexico
RandomizedCrossoverSingle-blindTreatment

Summary

Hypothesis: Cortical spreading depolarizations are inhibited by the NMDA receptor antagonist Ketamine Aim 1: To demonstrate, in a group of patients with acute severe brain injury requiring surgery including traumatic brain injury and aneurysmal subarachnoid hemorrhage, whether use of continuous infusion of ketamine decreases frequency of occurrence of cortical spreading depolarizations.

Timeline

Start
2015-07
Primary completion
2017-01-01
Completion
2017-05-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.1 mg